Filed: 2/14/2023ACC: 0000950123-23-002324
📋 What this filing means
SYNCONA PORTFOLIO LTD filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $63.00M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$63.00M
Total AUM (reported)
55.81M
Total Shares
Allocation by class
SPON ADS$40.56M64.4%
SPONSORED ADS$20.43M32.4%
SPONDS ADR$2.01M3.2%
Portfolio Concentration
Top 3$60.99M96.8%
4–10$2.01M3.2%
Top 3 weight
96.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 55.81M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
55.81M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings4
Rows:
AUTOLUS THERAPEUTICS PLC
OTRShares21.35M
TypeSH
Market value$40.56M
64.38%
Sole
0.00
Shared
21.35M
None
0.00
FREELINE THERAPEUTICS HLDGS
OTRShares22M
TypeSH
Market value$10.45M
16.59%
Sole
0.00
Shared
22M
None
0.00
ACHILLES THERAPEUTICS PLC
OTRShares11.09M
TypeSH
Market value$9.98M
15.84%
Sole
0.00
Shared
11.09M
None
0.00
ADAPTIMMUNE THERAPEUTICS PLC
OTRShares1.38M
TypeSH
Market value$2.01M
3.19%
Sole
0.00
Shared
1.38M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLCOTR | SPON ADS | 21.35M | SH | $40.56M 64.38% | 0.00 | 21.35M | 0.00 |
FREELINE THERAPEUTICS HLDGSOTR | SPONSORED ADS | 22M | SH | $10.45M 16.59% | 0.00 | 22M | 0.00 |
ACHILLES THERAPEUTICS PLCOTR | SPONSORED ADS | 11.09M | SH | $9.98M 15.84% | 0.00 | 11.09M | 0.00 |
ADAPTIMMUNE THERAPEUTICS PLCOTR | SPONDS ADR | 1.38M | SH | $2.01M 3.19% | 0.00 | 1.38M | 0.00 |